Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
GLAND:NSE
Gland Pharma Ltd
₹2,325.00
-0.26%
(-6.00) 1D
May 22, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAND...
Open
₹2,353.50
High
₹2,363.50
Low
₹2,307.20
Mkt. cap
383.06B
Avg. vol.
503.79K
Volume
864.27K
Dividend
0.86%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
37.33
52-wk high
₹2,370.00
52-wk low
₹1,512.10
EPS
₹62.28
No. of employees
4K
News stories
From sources across the web
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4.35K
Founded1978
Headquarters-
SectorPharmaceutical industry
Last report
May 15, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹22.23 / ₹15.78
+40.90%beat
Revenue / Est. (INR)
17.43B / 16.61B
+4.92%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.06B
14.87B
16.95B
17.43B
Cost of goods sold
5.67B
6.04B
6.31B
6.44B
Cost of revenue
5.67B
6.04B
6.31B
6.44B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08B
3.85B
4.24B
4.12B
Operating expense
6.72B
6.75B
7.37B
6.94B
Total operating expenses
12.39B
12.79B
13.68B
13.38B
Operating income
2.67B
2.08B
3.27B
4.04B
Other non operating income
575.27M
841.62M
631.73M
1.11B
EBT including unusual items
3.13B
2.84B
3.62B
5.06B
EBT excluding unusual items
3.13B
2.84B
3.86B
5.06B
Income tax expense
972.59M
1.00B
1.01B
1.39B
Effective tax rate
31.10%
35.30%
27.79%
27.51%
Other operating expenses
1.63B
1.84B
2.06B
1.74B
Net income
2.15B
1.84B
2.61B
3.67B
Net profit margin
14.31%
12.35%
15.42%
21.04%
Earnings per share
13.33
11.15
16.98
22.23
Interest and investment income
-
-
-
-
Interest expense
-114.96M
-78.23M
-39.30M
-100.30M
Net interest expenses
-114.96M
-78.23M
-39.30M
-100.30M
Depreciation and amortization charges
1.01B
1.06B
1.08B
1.09B
EBITDA
3.57B
3.11B
4.17B
5.10B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more